Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
- Technologies
- Circadian Neuroendocrine Resetting Therapy (CNRT)
- CNRT Overview Video References
- Photo Immuno-Resetting Therapy for the Treatment of Cancer
- Visit www.cycloset.com for
more information on the product

